Initial and Early Effects of Adriamycin in Murine Sarcoma 180 Cannot Be Restored in a Resistant Subline by Increasing the Uptake and External Concentration of the Drug

Overview

Journal Cancer Chemother Pharmacol

Specialty Oncology

Date 1989 Jan 1

PMID 2720889

Authors

J SONKA

U Schossig

M Vogt-Schaden

M Volm

Affiliations

Soon will be listed here.

Abstract

We demonstrate the early effects (1 day) of Adriamycin (ADM) on proliferation-stimulated and quiescent sensitive, and ADM-resistant cells of the murine tumor sarcoma 180 (S 180). By investigating cell-cycle distribution and thymidine labeling, it can be shown that sensitive cells are strongly affected by the drug, even in a proliferationarrested state. A remarkable but slow DNA synthesis is the prominent effect of this drug treatment on sensitive cells, even under nonstimulating conditions. In resistant cells, neither an increase in concentration nor a variation in drug uptake can induce effects that could be compared with those observed in the sensitive line. From these results we conclude that the early effects of ADM are not modulated by drug uptake.

References

Barlogie B, Drewinko B, Johnston D, Freireich E . The effect of adriamycin on the cell cycle traverse of a human lymphoid cell line. Cancer Res. 1976; 36(6):1975-9. View

Tapiero H, PATET J, Fourcade A, Huppert J . Chromosomal changes associated with resistance to doxorubicin: correlation with tumorigenicity. Anticancer Res. 1986; 6(2):203-8. View

Kessel D . Circumvention of resistance to anthracyclines by calcium antagonists and other membrane-perturbing agents. Cancer Surv. 1986; 5(1):109-27. View

Volm M, Lindner C . Detection of induced resistance in short-term-tests. Adriamycin-resistant sarcoma 180. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1978; 91(1):1-10. DOI: 10.1007/BF00305966. View

Goldstein S, Korczack L . Status of mitochondria in living human fibroblasts during growth and senescence in vitro: use of the laser dye rhodamine 123. J Cell Biol. 1981; 91(2 Pt 1):392-8. PMC: 2111971. DOI: 10.1083/jcb.91.2.392. View

Riehm H, Biedler J . Potentiation of drug effect by Tween 80 in Chinese hamster cells resistant to actinomycin D and daunomycin. Cancer Res. 1972; 32(6):1195-200. View

Siegfried J, Tritton T, Sartorelli A . Comparison of anthracycline concentrations in S180 cell lines of varying sensitivity. Eur J Cancer Clin Oncol. 1983; 19(8):1133-41. DOI: 10.1016/0277-5379(83)90039-1. View

Hill B, Whelan R, Rupniak H, Dennis L, Rosholt M . A comparative assessment of the in vitro effects of drugs on cells by means of colony assays or flow microfluorimetry. Cancer Chemother Pharmacol. 1981; 7(1):21-6. DOI: 10.1007/BF00258208. View

Dano K . Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. Biochim Biophys Acta. 1973; 323(3):466-83. DOI: 10.1016/0005-2736(73)90191-0. View

10.

SONKA J, Stohr M, Vogt-Schaden M, Volm M . Isopycnic density-gradient centrifugation: a separation parameter which improves flow cytometric measurements on heterogeneous tumors. Cytometry. 1983; 4(2):141-9. DOI: 10.1002/cyto.990040207. View

11.

SONKA J, Stohr M, Vogt-Schaden M, Volm M . Anthracycline resistance and consequences of the in situ-in vitro transfer. Cytometry. 1985; 6(5):437-44. DOI: 10.1002/cyto.990060508. View

12.

Summerhayes I, Lampidis T, Bernal S, Nadakavukaren J, Nadakavukaren K, Shepherd E . Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells. Proc Natl Acad Sci U S A. 1982; 79(17):5292-6. PMC: 346882. DOI: 10.1073/pnas.79.17.5292. View

13.

Horan P, Kappler J . Automated fluorescent analysis for cytotoxicity assays. J Immunol Methods. 1977; 18(3-4):309-16. DOI: 10.1016/0022-1759(77)90184-3. View

14.

Komitowski D, SONKA J, Schmitt B, Muto S . Quantitative description of nuclear morphology in assessing resistance of sarcoma 180 to adriamycin. Cytometry. 1987; 8(6):625-31. DOI: 10.1002/cyto.990080615. View

15.

Tokita N, Raju M . Cell cycle-dependent Adriamycin uptake in Chinese hamster cells. Eur J Cancer Clin Oncol. 1985; 21(2):243-7. DOI: 10.1016/0277-5379(85)90179-8. View

16.

Hill A, Schimke R . Increased gene amplification in L5178Y mouse lymphoma cells with hydroxyurea-induced chromosomal aberrations. Cancer Res. 1985; 45(10):5050-7. View

17.

Kleinberger T, ETKIN S, Lavi S . Carcinogen-mediated methotrexate resistance and dihydrofolate reductase amplification in Chinese hamster cells. Mol Cell Biol. 1986; 6(6):1958-64. PMC: 367734. DOI: 10.1128/mcb.6.6.1958-1964.1986. View

18.

Mirski S, Gerlach J, Cole S . Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin. Cancer Res. 1987; 47(10):2594-8. View

19.

Lothstein L, Horwitz S . Expression of phenotypic traits following modulation of colchicine resistance in J774.2 cells. J Cell Physiol. 1986; 127(2):253-60. DOI: 10.1002/jcp.1041270210. View

20.

Raza A, Bhayana R, Ucar K, Kirshner J, Preisler H . Differences between labeling index and DNA histograms in assessing S-phase cells from a homogeneous group of chronic phase CML patients. Cytometry. 1985; 6(5):445-51. DOI: 10.1002/cyto.990060509. View